References
- Barnholtz-Sloan J, Patel N, Rollison D, et al (2009). Incidence trends of invasive cervical cancer in the United States by combined race and ethnicity. Cancer Causes Control, 20, 1129-38. https://doi.org/10.1007/s10552-009-9317-z
- Eifel PJ, Winter K, Morris M, et al (2004). Pelvic irradiation with concurrent chemotherapy versus pelvic and paraaortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. J Clin Oncol, 22, 872-80. https://doi.org/10.1200/JCO.2004.07.197
- Harrison L, Blackwell K (2004). Hypoxia and anemia: factors in decreased sensitivity to radiation therapy and chemotherapy. Oncologist, 9, 31-40. https://doi.org/10.1634/theoncologist.9-90005-31
- Hernandez E, Donohue KA, Anderson LL, Heller PB, Stehman FB (2000). The significance of thrombocytosis in patients with locally advanced cervical carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol, 78, 137-42. https://doi.org/10.1006/gyno.2000.5838
- Idei T, Sakamoto H, Nalajima Y, et al (2003). Concurrent weekly nedaplatin-based radiotherapy for high risk recurrent and advanced cervical cancer. Gan To Kagaku Ryoho, 30, 505-9.
- Katanyoo K, Tangjitgamol S, Chongthanakorn M, et al (2011). Treatment outcomes of concurrent weekly carboplatin with radiation therapy in locally advanced cervical cancer patients. Gynecol Oncol, 123, 571-6. https://doi.org/10.1016/j.ygyno.2011.09.001
- Kim YS, Shin SS, Choi EK, et al (2005). A preliminary result of a randomized trial comparing monthly 5-flourouracil and cisplatin to weekly cisplatin alone combined with concurrent radiotherapy for locally advanced cervical cancer. Cancer Res Treat, 37, 37-43. https://doi.org/10.4143/crt.2005.37.1.37
- Kim YS, Shin SS, Nam JH, et al (2008). Prospective randomized comparison of monthly fluorouracil and cisplatin versus weekly cisplatin concurrent with pelvic radiotherapy and high-dose rate brachytherapy for locally advanced cervical cancer. Gynecol Oncol, 108, 195-200. https://doi.org/10.1016/j.ygyno.2007.09.022
- Klopp AH, Eifel PJ (2011). Chemoradiotherapy for cervical cancer in 2010. Curr Oncol Rep, 13, 77-85. https://doi.org/10.1007/s11912-010-0134-z
- Lee HN, Lee KH, Lee DW, et al (2011).Weekly cisplatin therapy compared with triweekly combination chemotherapy as concurrent adjuvant chemoradiation therapy after radical hysterectomy for cervical cancer. Int J Gynecol Cancer, 21, 128-36. https://doi.org/10.1097/IGC.0b013e318200f7c5
- Niibe Y, Hayakawa K, Tsunoda S, et al (2007). Phase II study of radiation therapy combined with weekly nedaplatin in locally advanced uterine cervical carcinoma:Kitasto Gynecologic Radiation Oncology Group (KGROG 0501). Jpn J Clin Oncol, 37, 70-2.
- Rose PG, Ali S, Watkins E, et al (2007). Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin,cisplatin-based combination chemotherapy, or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: a gynecologic oncology group study. J Clin Oncol, 25, 2804-10. https://doi.org/10.1200/JCO.2006.09.4532
- Rose PG, Bundy BN, Watkins EB, et al (1999). Concurrent cisplatin-based radiotherapy and chemotherapy for locally cervical cancer. N Engl J Med, 340, 1144-53. https://doi.org/10.1056/NEJM199904153401502
- Ryu SY, Lee WM, Kim K, et al (2011). Randomized clinical trial of weekly vs. triweekly cisplatin-based chemotherapy concurrent with radiotherapy in the treatment of locally advanced cervical cancer. Int J Radiat Oncol Biol Phys, 81, e577-81. https://doi.org/10.1016/j.ijrobp.2011.05.002
- Thomas GM (1999). Improved treatment for cervical cancerconcurrent chemotherapy and radiotherapy. N Engl J Med, 340, 1198-200. https://doi.org/10.1056/NEJM199904153401509
- Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR (2007). Practical methods for incorporating summary time-to-event data into meta-analysis. Trials, 7, 16.
- Torres MA, Jhingran A, Thames HD Jr, et al (2008). Comparison of treatment tolerance and outcomes in patients with cervical cancer treated with concurrent chemoradiotherapy in a prospective randomized trial or with standard treatment. Int J Radiat Oncol Biol Phys, 70, 118-25. https://doi.org/10.1016/j.ijrobp.2007.05.028
- Winter WE 3rd, Maxwell GL, Tian C, et al (2004). Association of hemoglobin level with survival in cervical carcinoma patients treated with concurrent cisplatin and radiotherapy: a Gynecologic Oncology Group study. Gynecol Oncol, 94, 495-501. https://doi.org/10.1016/j.ygyno.2004.04.008
Cited by
- Extended Field Radiotherapy With or Without Chemotherapy in Patients with Cervical Cancer and Positive Para-Aortic Lymph Nodes: a Single Institution Retrospective Review vol.16, pp.9, 2015, https://doi.org/10.7314/APJCP.2015.16.9.3827
- Weekly Versus Triweekly Cisplatin-Based Chemotherapy Concurrent With Radiotherapy in the Treatment of Cervical Cancer vol.27, pp.2, 2017, https://doi.org/10.1097/IGC.0000000000000883
- triweekly cisplatin with radiotherapy for locally advanced squamous-cell carcinoma of the cervix: a retrospective analysis from a single institution vol.90, pp.1076, 2017, https://doi.org/10.1259/bjr.20170241
- Significant Effect of Acupressure in Elevating Blood Stem Cell Factor During Chemotherapy in Patients With Gynecologic Cancer pp.1682-3141, 2018, https://doi.org/10.1097/JNR.0000000000000257
- Chemoradiotherapy completion and neutropenia risk in HIV patients with cervical cancer vol.97, pp.30, 2018, https://doi.org/10.1097/MD.0000000000011592